NEW YORK (GenomeWeb News) – Personalis has appointed Adam Lowe to be VP of marketing. He formerly was VP of commercial operations at Oxford Nanopore Technologies, and spent five years working at Illumina, where he worked on product marketing and management for next-gen sequencing. He also worked in scientific operations at Applied Biosystems, now a Life Technologies business, and business development at Agilent Technologies.
DNAnexus has appointed Omar Serang to chief cloud officer, a newly created position. In the position Serang will be responsible for driving product development roadmaps and managing compliance and integration efforts, as well as for designing and implementing cloud security and governance features.
He joins DNAnexus from Amazon Web Services. Previously, he held positions at Topsy Labs, Cloudmark, and Critical Path.
GeneNews said this week that Heiner Dreismann has stepped down from his post as interim CEO, although he continues to serve as lead director. Other management changes were made.
James Howard-Tripp has been appointed executive chair of the company's board of directors, replacing Rory Riggs, who has stepped down as chair but who remains a director. Howard-Tripp has served on the firm's board of directors since 2002. He most recently was president and CEO of Labopharm.
CombiMatrix has named Robert Hoffman to fill an empty seat on its seven-member board of directors. He is senior VP of finance and chief financial officer of Arena Pharmaceuticals, and he serves on two committees of the Association of Bioscience Financial Officers.
Quest Diagnostics said this week that Mark Guinan will be its next senior VP and CFO, effective July 29.
He has been CFO for Hill-Rom Holdings, a maker of medical technologies, since 2010, and he formerly worked in finance and operations roles at Johnson and Johnson and at Procter and Gamble.
Pharmacogenomics and biorepository solutions firm Gentris said this week that it has named Amelia Warner to be its new president. In the post, she will oversee US operations, lead development of new service offerings, and develop education and science training programs for biobanking and pharmacogenomics.
Warner most recently was head of clinical pharmacogenomics and clinical specimen management at Merck Research Laboratories, and she is the CEO and founder of Global Specimen Solutions. She also completed a fellowship at St. Jude Children's Research Hospital in clinical pharmacology and pharmacogenomics.
Canadian Prime Minister Stephen Harper has appointed Greg Rickford to be the country's science and technology minister, replacing Gary Goodyear.
Rickford previously was parliamentary secretary to the Minister of Indian Affairs and Northern Development, and he has held other political appointments. He previously worked as a lawyer and as a nurse and healthcare consultant.
In the job, he reports to Industry Canada, which oversees most of Canada's science agencies, including Genome Canada and the Canadian Foundation for Innovation.
Jason Moore, a professor in Dartmouth College's Geisel School of Medicine has been named a Kavli Fellow of the National Academy of Sciences for 2013 for his work in translational bioinformatics and personalized medicine.
Moore is a professor of genetics and of community and family medicine at Geisel, director of Dartmouth's Institute for Quantitative Biomedical Sciences, and associate director for bioinformatics at Norris Cotton Cancer Center at Dartmouth
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.